High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza

This study has been completed.
Sponsor:
Collaborators:
Wellcome Trust
Global Influenza Program World Health Organization
University of Oxford
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00298233
First received: March 1, 2006
Last updated: March 18, 2010
Last verified: October 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2010
  Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
No publications provided by National Institute of Allergy and Infectious Diseases (NIAID)

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):